These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multimodal nanoprobes to target cerebrovascular amyloid in Alzheimer's disease brain. Jaruszewski KM; Curran GL; Swaminathan SK; Rosenberg JT; Grant SC; Ramakrishnan S; Lowe VJ; Poduslo JF; Kandimalla KK Biomaterials; 2014 Feb; 35(6):1967-76. PubMed ID: 24331706 [TBL] [Abstract][Full Text] [Related]
3. Chitosan enhances the stability and targeting of immuno-nanovehicles to cerebro-vascular deposits of Alzheimer's disease amyloid protein. Jaruszewski KM; Ramakrishnan S; Poduslo JF; Kandimalla KK Nanomedicine; 2012 Feb; 8(2):250-60. PubMed ID: 21704598 [TBL] [Abstract][Full Text] [Related]
4. Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer's disease and cerebral amyloid angiopathy. Agyare EK; Curran GL; Ramakrishnan M; Yu CC; Poduslo JF; Kandimalla KK Pharm Res; 2008 Nov; 25(11):2674-84. PubMed ID: 18712585 [TBL] [Abstract][Full Text] [Related]
5. Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy. Han BH; Zhou ML; Vellimana AK; Milner E; Kim DH; Greenberg JK; Chu W; Mach RH; Zipfel GJ Mol Neurodegener; 2011 Dec; 6():86. PubMed ID: 22192811 [TBL] [Abstract][Full Text] [Related]
6. 99mTc(CO)3-Labeled Benzothiazole Derivatives Preferentially Bind Cerebrovascular Amyloid: Potential Use as Imaging Agents for Cerebral Amyloid Angiopathy. Jia J; Cui M; Dai J; Liu B Mol Pharm; 2015 Aug; 12(8):2937-46. PubMed ID: 26065726 [TBL] [Abstract][Full Text] [Related]
7. Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice. Merlini M; Meyer EP; Ulmann-Schuler A; Nitsch RM Acta Neuropathol; 2011 Sep; 122(3):293-311. PubMed ID: 21688176 [TBL] [Abstract][Full Text] [Related]
8. Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice. Xu F; Kotarba AE; Ou-Yang MH; Fu Z; Davis J; Smith SO; Van Nostrand WE J Biol Chem; 2014 Jun; 289(25):17895-908. PubMed ID: 24828504 [TBL] [Abstract][Full Text] [Related]
17. Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy. Vasilevko V; Passos GF; Quiring D; Head E; Kim RC; Fisher M; Cribbs DH Ann N Y Acad Sci; 2010 Oct; 1207():58-70. PubMed ID: 20955427 [TBL] [Abstract][Full Text] [Related]
18. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides. Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814 [TBL] [Abstract][Full Text] [Related]